Showing drug card for 5-Methoxy-N,N-diisopropyltryptamine (DB01441)
Legend: drug field target field enzyme field
| Version | 2.5 |
| Creation Date | 2007-07-31 13:09:35 |
| Update Date | 2008-08-26 13:57:53 |
| Primary Accession Number | DB01441 |
| Secondary Accession Number | Not Available |
| Name | 5-Methoxy-N,N-diisopropyltryptamine |
| Drug Type |
|
| Description | 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) is a tryptamine derivative and shares many similarities with schedule I tryptamine hallucinogens such as alpha-ethyltryptamine, N,N-dimethyltryptamine, N,N-diethyltryptamine, bufotenine, psilocybin and psilocin. Since 1999, there has been a growing popularity of 5-MeO-DIPT among drug abusers. This substance is abused for its hallucinogenic effects. |
| Synonyms |
|
| Brand Names | Not Available |
| Brand Mixtures | Not Available |
| Chemical IUPAC Name | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-propan-2-ylpropan-2-amine |
| Chemical Formula | C17H26N2O |
| Chemical Structure | |
| CAS Registry Number | 4021-34-5 |
| InChI Identifier | InChI=1/C17H26N2O/c1-12(2)19(13(3)4)9-8-14-11-18-17-7-6-15(20-5)10-16(14)17/h6-7,10-13,18H,8-9H2,1-5H3 |
| InChI Key | DNBPMBJFRRVTSJ-UHFFFAOYAF |
| KEGG Drug | Not Available |
| KEGG Compound | Not Available |
| PubChem Compound | 151182  |
| PubChem Substance | 10251046 |
| ChEBI ID | Not Available |
| PharmGKB ID | Not Available |
| HET ID | Not Available |
| GenBank ID | Not Available |
| Drug ID Number [DIN] | Not Available |
| RxList Link | Not Available |
| PDRhealth Link | Not Available |
| Wikipedia Link | http://en.wikipedia.org/wiki/5-Methoxy-diisopropyltryptamine |
| FDA Label | Not Available |
| Material Safety Data Sheet (MSDS) | Not Available |
| Synthesis Reference | Not Available |
| Average Molecular Weight | 274.4011 |
| Monoisotopic Molecular Weight | 274.2045 |
| State | Solid |
| Melting Point | 181 oC |
| Experimental Water Solubility | Not Available Source: PhysProp |
| Predicted Water Solubility | 6.73e-02 mg/mL Calculated using ALOGPS |
| Experimental LogP/Hydrophobicity | Not Available Source: PhysProp |
| Predicted LogP | 4.35 Calculated using ALOGPS |
| Experimental LogS | Not Available |
| Predicted LogS | -3.61 Calculated using ALOGPS |
| Experimental Caco2 Permeability | Not Available |
| pKa/Isoelectric Point | Not Available |
| Mass Spectrum | Not Available |
| MOL File | Show | Download |
| SDF File | Show | Download |
| PDB File | Show | Download |
| 2D Structure | |
| 3D Structure | |
| Experimental PDB ID | Not Available |
| Isomeric SMILES | COC1=CC2=C(NC=C2CCN(C(C)C)C(C)C)C=C1 |
| Canonical SMILES | COC1=CC2=C(NC=C2CCN(C(C)C)C(C)C)C=C1 |
| Drug Category |
|
| ATC Codes | Not Available |
| AHFS Codes | Not Available |
| Indication | Not Available |
| Pharmacology | 5-methoxy-diisopropyltryptamine, also known as 5-methoxy-N,N-diisopropyltryptamine, 5-MeO-DiPT, foxy methoxy, or just foxy, is a tryptamine that is used recreationally as a psychedelic. 5-MeO-DiPT is orally active, and dosages between 6–20 mg are commonly reported. Many users note an unpleasant body load accompanies higher dosages. 5-MeO-DiPT is also taken by insufflation, or sometimes it is smoked or injected. Some users also report sound distortion, also noted with the related drug, DiPT. |
| Mechanism of Action | Not Available |
| Absorption | 5-MeO-DIPT produces effects with an onset of 20 to 30 minutes and with peak effects occurring between 1 to 1.5 hours after administration. |
| Toxicity | Not Available |
| Protein Binding | Not Available |
| Biotransformation | Not Available |
| Half Life | Not Available |
| Dosage Forms | Not Available |
| Patient Information | Not Available |
| Contraindications | Not Available |
| Interactions | Not Available |
| Drug Interactions | Not Available |
| Food Interactions | Not Available |
| Pathways | Not Available |
| General References | |
| Organisms Affected |
|